| Fund ID | 805-4181365113 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 100% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| New Leaf Biopharma Opportunities II, L.P. | Venture Capital | $131.9M |
| New Leaf Ventures IV, L.P. | Venture Capital | $118.9M |
| New Leaf Ventures III, L.P. | Venture Capital | $100.5M |
Nlv Co-Invest III, LLC reports $3.2 million in gross assets, among the top 88% of private funds by size.
Nlv Co-Invest III, LLC is managed by New Leaf Venture Partners LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.